Gemcitabina en 4 pacientes con colangiocarcinoma / Gemcitabine in the treatment of cholangiocarcinoma: report of 4 cases
Rev. méd. Chile
;
129(8): 911-916, ago. 2001. ilus, tab
Article
Dans Espagnol
| LILACS
| ID: lil-300152
ABSTRACT
Cholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects of chemotherapy, with a very small response. We report four patients with advanced cholangiocarcinoma, treated with gemcitabine 1000 mg/m2, weekly for 3 weeks every 28 days. There was a stabilization of tumor size and symptoms were alleviated. Toxicity was low and there was a probable prolongation of survival
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Tumeurs des canaux biliaires
/
Cholangiocarcinome
/
Désoxycytidine
/
Antinéoplasiques
Limites du sujet:
Humains
/
Mâle
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2001
Type:
Article
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Universidad de Chile/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS